Most Recent

  • 16 Nov 2010

High-Risk, High-Reward

Our new report on Asia Pacific Pharma companies' R&D; activity.

  • 13 Sep 2010

The Influence of Reform on Local Coverage and Utilization

This paper explores the features of healthcare reform that pertain to insurance coverage and utilization projections and presents methods for estimating insurance coverage changes in a local market.

Recommended

Hospital Operational and Financial Performance Improving

Healthcare Hospital Operational Performance Improving

Who's Making the Biggest Splash?

Expert, measured insight into organizations that helped to shape professional opinions on drugs and therapies, using the unique insights of the Thomson Reuters Medical Literature AnalyzerSM.

Recommended

Most Recent

  • 13 Sep 2010

The Influence of Reform on Local Coverage and Utilization

This paper explores the features of healthcare reform that pertain to insurance coverage and utilization projections and presents methods for estimating insurance coverage changes in a local market.

  • 13 Aug 2010

How Big is the Market? (The IPV/OPV white paper)

This white paper demonstrates the utility of using the Inpatient View and Outpatient View online tools from Thomson Reuters to quickly size a market for a medical device or technology.

  • 09 Jul 2010

The Shifting Landscape in Pediatric Demand: Emerging Trends in Sites of Service, Conditions Treated, and Patient Demographics

This white paper discusses explores the shifting volumes of pediatric patients from one type of facility to another for specific conditions, as well as age shifts in pediatric populations with certain conditions.

  • 05 Oct 2009

Pinpoint and Capture Profitable Outpatient Business

This white paper discusses findings that show strategic growth opportunities can be found in understanding the relationship between local market volumes, growth rates, and generational segments.

Most Recent

  • 16 Nov 2010

High-Risk, High-Reward

Our new report on Asia Pacific Pharma companies' R&D; activity.

  • 12 Aug 2009

Outlook and Issues for the Biotechnology Sector

A comprehensive assessment of Wall Street’s perception of and outlook for the biotechnology sector. This analysis aims to provide companies with an insider’s perspective on what the investment community values in the current economic climate, including cash position, pipeline, regulatory environment, upcoming catalysts, and IR communications, among others.

Recommended

Who's Making the Biggest Splash?

Expert, measured insight into organizations that helped to shape professional opinions on drugs and therapies, using the unique insights of the Thomson Reuters Medical Literature AnalyzerSM.